Evolent Health (EVH) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | 55.7 | 43.7 | -24.8 | 84.9 | 111.4 | 102.5 | |
| Changes by years, y/y, % | -123% | -21% | -157% | -442% | +31% | |||
Evolent Health. EBITDA US GAAP, bln rub
Evolent Health. EBITDA US GAAP, changes, %
Evolent Health. EBITDA US GAAP, sum by quarters, bln rub
Evolent Health (EVH) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -28.7 | 27.3 | 27.5 | 35.4 | 12.3 | 102.5 | |
| Changes by years, y/y, % | -253% | -25% | +130% | +166% | -143% | |||
| Changes by quarters, q/q, % | -316% | -195% | +1% | +29% | -65% | |||